Methylene blue induces mitochondrial complex iv and improves cognitive function and grip strength in old mice

Neurodegeneration: Theory, Disorders and Treatments

Volumn , Issue , 2011, Pages 63-86

  Gharib, Afshin ^b,c   Atamna, Hani ^a  

^a Janet Weis Children s Hospital   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c DOMINICAN UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Alz heimer's diseases; Brain; Complex IV; Methylene blue; Mitochondria; Senescence

Indexed keywords

EID: 84867567259     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (86)

1. Mosconi, L., Tsui, W. H., De Santi, S., Li, J., Rusinek, H., Convit, A., Li, Y., Boppana, M. & de Leon, M. J. (2005). Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology, 64, 1860-1867.
2. Huang J. H. & Hood, D. A. (2009). Age-associated mitochondrial dysfunction in skeletal muscle: Contributing factors and suggestions for long-term interventions. IUBMB Life, 61, 201-214.
3. Moreira, P. I., Cardoso, S. M., Pereira, C. M., Santos, M. S. & Oliveira, C. R. (2009). Mitochondria as a therapeutic target in Alzheimer's disease and diabetes. CNS Neurol Disord Drug Targets, 8, 492-511.
4. Navarro, A., Lopez-Cepero, J. M., Bandez, M. J., Sanchez-Pino, M. J., Gomez, C., Cadenas, E. & Boveris, A. (2008). Hippocampal mitochondrial dysfunction in rat aging. Am J Physiol Regul Integr Comp Physiol, 294, R501-509.
5. McGinnis, S. L. & Moore, J. (2006). The impact of the aging population on the health workforce in the United States--summary of key findings. Cah Sociol Demogr Med, 46, 193-220.
6. Goldberg, A., Dengel, D. & Hagberg, J. (1996). Exercise physiology and aging., Academic Press., San Diego.
7. Thouvarecq, R., Protais, P., Jouen, F. & Caston, J. (2001). Influence of cholinergic system on motor learning during aging in mice. Behav Brain Res, 118, 209-218.
8. Barnes, C. A. (1988). Aging and the physiology of spatial memory. Neurobiol Aging, 9, 563-568.
9. Mallau, S. & Simoneau, M. (2009). Aging reduces the ability to change grip force and balance control simultaneously. Neurosci Lett, 452, 23-27.
10. Finkel, D., Andel, R., Gatz, M. & Pedersen, N. L. (2009). The role of occupational complexity in trajectories of cognitive aging before and after retirement. Psychol Aging, 24, 563-573.
11. Cui, L., Hofer, T., Rani, A., Leeuwenburgh, C. & Foster, T. C. (2009). Comparison of lifelong and late life exercise on oxidative stress in the cerebellum. Neurobiol Aging, 30, 903-909.
12. Shukitt-Hale, B., Cheng, V. & Joseph, J. A. (2009). Effects of blackberries on motor and cognitive function in aged rats. Nutr Neurosci, 12, 135-140.
13. Meyer, O. A., Tilson, H. A., Byrd, W. C. & Riley, M. T. (1979). A method for the routine assessment of fore-and hindlimb grip strength of rats and mice. Neurobehav Toxicol, 1, 233-236.
14. Morris, R. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods, 11, 47-60.
15. Gage, F. H., Dunnett, S. B. & Bjorklund, A. (1984). Spatial learning and motor deficits in aged rats. Neurobiol Aging, 5, 43-48.
16. Baloyannis, S. J. (2006). Mitochondrial alterations in Alzheimer's disease. J Alzheimers Dis, 9, 119-126.
17. Atamna, H,. Nguyen, A., Schultz, C., Boyle, K., Newberry, J., Kato, H., Ames, B. N. (2008). Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. Faseb J, 22, 703-712.
18. Wagner, G. (2006). Towards a life prolonging pill? Small molecules with anti-ageing properties. Curr Drug Targets, 7, 1531-1537.
19. Clifton, J. & 2nd, Leikin, J. B. (2003) Methylene blue. Am J Ther, 10, 289-291.
20. Patel, P. N. (2006). Methylene blue for management of Ifosfamide-induced encephalopathy. Ann Pharmacother, 40, 299-303.
21. Pelgrims, J., De Vos, F., Van den Brande, J., Schrijvers, D., Prove, A. & Vermorken, J. B. (2000). Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. Br J Cancer, 82, 291-294.
22. Betten, D. P., Vohra, R. B., Cook, M. D., Matteucci, M. J. & Clark, R. F. (2006). Antidote use in the critically ill poisoned patient. J Intensive Care Med, 21, 255-277.
23. Sweet, G. & Standiford, S. B. (2007). Methylene-blue-associated encephalopathy. J Am Coll Surg, 204, 454-458.
24. Naylor, G. J., Martin, B., Hopwood, S. E. & Watson, Y. (1986). A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis. Biol Psychiatry, 21, 915-920.
25. de-Oliveira, R. W. & Guimaraes, F. S. (1999). Anxiolytic effect of methylene blue microinjected into the dorsal periaqueductal gray matter. Braz J Med Biol Res, 32, 1529-1532.
26. Eroglu, L. & Caglayan, B. (1997). Anxiolytic and antidepressant properties of methylene blue in animal models. Pharmacol Res, 36, 381-385.
27. Demirbilek, S., Sizanli, E., Karadag, N., Karaman, A., Bayraktar, N., Turkmen, E. & Ersoy, M. O. (2006). The effects of methylene blue on lung injury in septic rats. Eur Surg Res, 38, 35-41.
28. Meissner, P. E., Mandi, G., Witte, S., Coulibaly, B., Mansmann, U., Rengelshausen, J., Schiek, W., Jahn, A., Sanon, M., Tapsoba, T., Walter-Sack, I., Mikus, G., Burhenne, J., Riedel, K. D., Schirmer, H., Kouyate, B. & Muller, O. (2005). Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]. Malar J, 4, 45.
29. Rezzani, R., Rodella, L., Corsetti, G. & Bianchi, R. (2001). Does methylene blue protect the kidney tissues from damage induced by ciclosporin A treatment? Nephron, 89, 329-336.
30. Haluzik, M., Nedvidkova, J. & Skrha, J. (1999). Treatment with the NO-synthase inhibitor, methylene blue, moderates the decrease in serum leptin concentration in streptozotocin-induced diabetes. Endocr Res, 25, 163-171.
31. Salaris, S. C., Babbs, C. F. & Voorhees, W. D. 3rd (1991). Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. Biochem Pharmacol, 42, 499-506.
32. Chung, S. O. & Nam, S. Y. (1975). The radioprotective effect against gamma-irradiation of methylene blue in the rat with reference to serum enzymes and pancreatic protein fractions examined by isoelectric focusing. J Radiat Res (Tokyo), 16, 211-223.
33. Teicher, B. A., Herman, T. S. & Kaufmann, M. E. (1990). Cytotoxicity, radiosensitization, and DNA interaction of platinum complexes of thiazin and xanthene dyes. Radiat Res, 121, 187-195.
34. Visarius, T. M., Stucki, J. W. & Lauterburg, B. H. (1999). Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats. J Pharmacol Exp Ther, 289, 820-824.
35. Necula, M., Breydo, L., Milton, S., Kayed, R., van der Veer, W. E., Tone, P., Glabe, C. G. (2007). Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. Biochemistry, 46, 8850-8860.
36. Kucukkilinc, T. & Ozer, I. (2007). Multi-site inhibition of human plasma cholinesterase by cationic phenoxazine and phenothiazine dyes. Arch Biochem Biophys, 461, 294-298.
37. Martinez, J. L., Jensen, R. A., Vasquez, B. J., Mcguinness, T. & Mcgaugh, J. l. (1978). Methylene blue alters retention of inhibitory avoiddance responses Physiological Psychology, 6, 387-390.
38. Callaway, N. L, Riha, P. D., Bruchey, A. K., Munshi, Z. & Gonzalez-Lima, F. (2004). Methylene blue improves brain oxidative metabolism and memory retention in rats. Pharmacol Biochem Behav, 77, 175-181.
39. Furian, A. F., Fighera, M. R., Oliveira, M. S., Ferreira, A. P., Fiorenza, N. G., de Carvalho Myskiw, J., Petry, J. C., Coelho, R. C., Mello, C. F. & Royes, L. F. (2007). Methylene blue prevents methylmalonate-induced seizures and oxidative damage in rat striatum. Neurochem Int, 50, 164-171.
40. Zhang, X., Rojas, J. C. & Gonzalez-Lima, F. (2006). Methylene blue prevents neurodegeneration caused by rotenone in the retina. Neurotox Res, 9, 47-57.
41. Wagner, S. J., Cifone, M. A., Murli, H., Dodd, R. Y. & Myhr, B. (1995). Mammalian genotoxicity assessment of methylene blue in plasma: implications for virus inactivation. Transfusion, 35, 407-413.
42. Gabrielli, D., Belisle, E., Severino, D., Kowaltowski, A. J. & Baptista, M. S. (2004). Binding, aggregation and photochemical properties of methylene blue in mitochondrial suspensions. Photochem Photobiol, 79, 227-232.
43. Dierks, E. A. & Burstyn, J. N. (1998). The deactivation of soluble guanylyl cyclase by redox-active agents. Arch Biochem Biophys, 351, 1-7.
44. Mayer, B., Brunner, F. & Schmidt, K. (1993). Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol, 45, 367-374.
45. Oxenkrug, G. F., Sablin, S. O. & Requintina, P. J. (2007). Effect of Methylene Blue and Related Redox Dyes on Monoamine Oxidase Activity; Rat Pineal Content of N-Acetylserotonin, Melatonin, and Related Indoles; and Righting Reflex in Melatonin-Primed Frogs. Ann N Y Acad Sci, 1122, 245-252.
46. Riedel, W., Lang, U., Oetjen, U., Schlapp, U. & Shibata, M. (2003). Inhibition of oxygen radical formation by methylene blue, aspirin, or alpha-lipoic acid, prevents bacterial-lipopolysaccharide-induced fever. Mol Cell Biochem, 247, 83-94.
47. Zacharakis, N., Tone, P., Flordellis, C. S., Maragoudakis, M. E. & Tsopanoglou, N. E. (2006) Methylene blue inhibits angiogenesis in chick chorioallontoic membrane through a nitric oxide-independent mechanism. J Cell Mol Med, 10, 493-498.
48. Marshall, P. N. & Lewis, S. M. (1974). A rapid thin-layer chromatographic system for Romanowsky blood stains. Stain Technol, 49, 235-240.
49. Birth-Machin, M. J. S, Kler, R. S. & Tunbull, D. M. (1993). Study of skeletal muscle mitochondria Dysfunction in Methods in Toxicology: Mitochondrial Dysfunction, Lash L. H. and Jones D. P. eds, (Academic Press) pp 51-68, New York.
50. De Haan, L. H., Boerboom, A. M., Rietjens, I. M., van Capelle, D., De Ruijter, A. J., Jaiswal, A. K. & Aarts, J. M. (2002). A physiological threshold for protection against menadione toxicity by human NAD(P)H:quinone oxidoreductase (NQO1) in Chinese hamster ovary (CHO) cells. Biochem Pharmacol, 64, 1597-1603.
51. Rengelshausen, J., Burhenne, J., Frohlich, M., Tayrouz, Y., Singh, S. K., Riedel, K. D., Muller, O., Hoppe-Tichy, T., Haefeli, W. E., Mikus, G. & Walter-Sack, I. (2004). Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria. Eur J Clin Pharmacol, 60, 709-715.
52. Dhahbi, J. M., Mote, P. L., Fahy, G. M. & Spindler, S. R. (2005). Identification of potential caloric restriction mimetics by microarray profiling. Physiol Genomics, 23, 343-350.
53. Naber, D. & Dahnke, H. G. (1979). Protein and nucleic acid content in the aging human brain. Neuropathol Appl Neurobiol, 5, 17-24.
54. Wiggins, R. C., Gorman, A., Rolsten, C., Samorajski, T., Ballinger, W. E. & Jr., Freund G. (1988). Effects of aging and alcohol on the biochemical composition of histologically normal human brain. Metab Brain Dis, 3, 67-80.
55. Kwong, L. K. & Sohal, R. S. (2000). Age-related changes in activities of mitochondrial electron transport complexes in various tissues of the mouse. Arch Biochem Biophys, 373, 16-22.
56. Sohal, R. S. (1993). Aging, cytochrome oxidase activity, and hydrogen peroxide release by mitochondria. Free Radic Biol Med, 14, 583-588.
57. Zhang, J., Block, E. R. & Patel, J. M. (2002). Down-regulation of mitochondrial cytochrome c oxidase in senescent porcine pulmonary artery endothelial cells. Mech Ageing Dev, 123, 1363-1374.
58. Itoh, K., Weis, S., Mehraein, P. & Muller-Hocker, J. (1996). Cytochrome c oxidase defects of the human substantia nigra in normal aging. Neurobiol Aging, 17, 843-848.
59. Parker, W. D., Jr., Filley, C. M. & Parks, J. K. (1990). Cytochrome oxidase deficiency in Alzheimer's disease. Neurology, 40, 1302-1303.
60. Ramsay, R. R., Dunford, C. & Gillman, P. K. (2007). Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol, 152, 946-951.
61. Saura, J., Luque, J. M., Cesura, A. M., Da Prada, M., Chan-Palay, V., Huber, G., Loffler, J. & Richards, J. G. (1994). Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience, 62, 15-30.
62. Saura, J., Richards, J. G. & Mahy, N. (1994). Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs. Neurobiol Aging, 15, 399-408.
63. Burchinsky, S. G. & Kuznetsova, S. M. (1992). Brain monoamine oxidase and aging: a review. Arch Gerontol Geriatr, 14, 1-15.
64. Carlsson, A., Adolfsson, R., Aquilonius, S. M., Gottfries, C. G., Oreland, L., Svennerholm, L. & Winblad, B. (1980). Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. Adv Biochem Psychopharmacol, 23, 295-304.
65. Callaway, N. L., Riha, P. D., Wrubel, K. M., McCollum, D. & Gonzalez-Lima, F. (2002). Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats. Neurosci Lett, 332, 83-86.
66. Peter, C., Hongwan, D., Kupfer, A. & Lauterburg, B. H. (2000). Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol, 56, 247-250.
67. Capaldi, R. A. (1982). Arrangement of proteins in the mitochondrial inner membrane. Biochim Biophys Acta, 694, 291-306.
68. Kushnareva, Y., Murphy, A. N. & Andreyev, A. (2002). Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem J, 368, 545-553.
69. Barros, M. H., Bandy, B., Tahara, E. B. & Kowaltowski, A. J. (2004). Higher respiratory activity decreases mitochondrial reactive oxygen release and increases life span in Saccharomyces cerevisiae. J Biol Chem, 279, 49883-49888.
70. Cadenas, E. (2004). Mitochondrial free radical production and cell signaling. Mol Aspects Med, 25, 17-26.
71. Wong-Riley, M. T. (1989). Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci, 12, 94-101.
72. Luques, L., Shoham, S. & Weinstock, M. (2007). Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil. Exp Neurol, 206, 209-219.
73. Bennett, M. C., Diamond, D. M., Stryker, S. L., Parks, J. K. & Parker, W. D. Jr. (1992). Cytochrome oxidase inhibition: a novel animal model of Alzheimer's disease. J Geriatr Psychiatry Neurol, 5, 93-101.
74. Eisch, A. J., Cameron, H. A., Encinas, J. M., Meltzer, L. A., Ming, G. L., Overstreet-Wadiche, L. S. (2008). Adult neurogenesis, mental health, and mental illness: hope or hype? J Neurosci, 28, 11785-11791.
75. Arlotta, P., Magavi, S. S. & Macklis, J. D. (2003). Molecular manipulation of neural precursors in situ: induction of adult cortical neurogenesis. Exp Gerontol, 38, 173-182.
76. Bernal, G. M. & Peterson, D. A. (2004). Neural stem cells as therapeutic agents for age-related brain repair. Aging Cell, 3, 345-351.
77. Longo, F. M., Yang, T., Xie, Y. & Massa, S. M. (2006). Small molecule approaches for promoting neurogenesis. Curr Alzheimer Res, 3, 5-10.
78. Luo, J., Daniels, S. B., Lennington, J. B., Notti, R. Q. & Conover, J. C. (2006). The aging neurogenic subventricular zone. Aging Cell, 5, 139-152.
79. Danzer, S. C. (2008). Postnatal and adult neurogenesis in the development of human disease. Neuroscientist, 14, 446-458.
80. Drapeau, E. & Nora Abrous, D. (2008). Stem cell review series: role of neurogenesis in age-related memory disorders. Aging Cell, 7, 569-589.
81. Olariu, A., Cleaver, K. M. & Cameron, H. A. (2007). Decreased neurogenesis in aged rats results from loss of granule cell precursors without lengthening of the cell cycle. J Comp Neurol, 501, 659-667.
82. Donovan, M. H., Yazdani, U., Norris, R. D., Games, D., German, D. C. & Eisch, A. J. (2006). Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. J Comp Neurol, 495, 70-83.
83. Conboy, I. M. & Rando, T. A. (2005). Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle, 4, 407-410.
84. Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z. & Nilsen, J. (2008). Progesterone receptors: form and function in brain. Front Neuroendocrinol, 29, 313-339.
85. Kim, S. J., Son, T. G., Park, H. R., Park, M., Kim, M. S., Kim, H. S., Chung, H. Y., Mattson, M. P. & Lee, J. (2008). Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem, 283, 14497-14505.
86. Zhang, R. L., Zhang, Z., Zhang, L., Wang, Y., Zhang, C. & Chopp, M. (2006). Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia. J Neurosci Res, 83, 1213-1219.